XML 24 R12.htm IDEA: XBRL DOCUMENT v3.25.3
Accounts payable and accrued expenses
9 Months Ended
Sep. 30, 2025
Accounts payable and accrued expenses  
Accounts payable and accrued expenses

5.        Accounts payable and accrued expenses

Accounts payable and accrued expenses at September 30, 2025 and December 31, 2024 consist of the following:

September 30, 

December 31, 

    

2025

    

2024

Employee compensation, benefits, and related accruals

$

49,466

$

61,575

Income tax payable

2,927

4,701

Consulting and contracted research

 

19,961

 

19,909

Sales allowance

 

55,302

 

58,644

Sales rebates

 

83,850

 

101,613

Royalties

5,146

8,953

Accounts payable

 

36,617

 

17,274

Milestone payable

32,500

11,025

Other

 

17,372

 

20,598

Total

$

303,141

$

304,292

As of September 30, 2025, the Company does not have any accrued restructuring costs included above within employee compensation, benefits, and related accruals. As of December 31, 2024, there were $0.1 million of accrued restructuring costs included above within employee compensation, benefits, and related accruals from a reduction in workforce in the year ended December 31, 2023 in connection with the Company’s strategic pipeline prioritization and discontinuation of its preclinical and early research programs in its gene therapy platform.